Skip to content

Public FDA record

Z-2041-2012: Varian brand Varian Eclipse Treatment Planning System for radiotherapy; Model Number: H48; Product is ma

Recall record Z-2041-2012 for Varian Medical Systems, Inc. Oncology Systems. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2041-2012
Company in FDA record
Varian Medical Systems, Inc. Oncology Systems
FDA classification date
Jul 19, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Class II

Reason stated in the source

Varian has identified an anomaly with the Eclipse Treatment Planning (for radiotherapy treatments) where changing the prescription in a calculated VMAT or RapidArc plan may lead to Monitor Units which do not reflect the new prescription. If the dose prescription of a VMAT or RapidArc plan is changed after the initial Dose Volume Optimization, the Monitor Units and dose distribution may not reflect

Source facts

Action
The firm, VARIAN Medical Systems, sent an "URGENT MEDICAL DEVICE CORRECTION; URGENT FIELD SAFETY NOTICE" dated June 18, 2012, to all affected users. The notice described the product, problem and actions to be taken. Varian is developing a technical correction for this issue. The customers will be contacted by a Varian Customer Service representative when this correction is available to schedule its installation. If you require further clarification, please feel free to contact your local Varian Medical Systems Customer Support District or Regional Manager. In USA and Canada: 1.888.VARIAN5 (888.827.4265) Europe: +41 41 749 8844; email: support-emea@varian.com Email: North America: support-americas@varian.com; Australia/New Zealand: support-anz@varian.com; South East Asia: support-sea@varian.com; China/Asia: support-china@varian.com; Japan: support-japan@varian.com and Latin America: soporte.al@varian.com. Internet: Oncology systems customer site - www.myvarian.com and Varian Medical Systems public site - www.varian.com.
Initiated
2012-06-18
Root cause
Software design (manufacturing process)
Terminated
2014-08-06
Distribution
Worldwide distribution: USA (nationwide) and countries including of: Austria, Australia, Bahrain, Belgium, Brazil, Canada, China, Chile, Colombia, Denmark, Egypt, Finland, France,Germany, Greece, Hungary, Hong Kong, India, Indonesia, Israel, Ireland, Italy, Japan, Latvia, Malaysia, Mexico, Morocco, Nepal, Netherlands, Norway, Panama, Poland, Portugal, Puerto Rico, Romania, Saudi Arabia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, United Kingdom, Taiwan, Turkey, Ukraine, United Arab Emirates and Venezuela.
Recall number
Z-2041-2012
Recall status
Terminated
CDRH record ID
110464
FDA classified
2012-07-19
Recall event number
62420

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗